RAAS: A Convergent Player in Ischemic Heart Failure and Cancer
The current global prevalence of heart failure is estimated at 64.34 million cases, and it is expected to increase in the coming years, especially in countries with a medium-low sociodemographic index where the prevalence of risk factors is increasing alarmingly. Heart failure is associated with man...
Main Authors: | Texali C. Garcia-Garduño, Jorge R. Padilla-Gutierrez, Diego Cambrón-Mora, Yeminia Valle |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/13/7106 |
Similar Items
-
Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction
by: Masanobu Ishii, MD, et al.
Published: (2017-12-01) -
Effect of vitamin D intervention on the RAAS system activity and cardiovascular remodeling in spontaneously hypertensive rats
by: Hui Li1, et al.
Published: (2017-04-01) -
Correlation between serum Copeptin and myocardial damage degree as well as RAAS system activation in patients with acute coronary syndrome (ACS)
by: Jing-Wen Xia
Published: (2017-04-01) -
Impact of Chronic RAAS Use in Elderly COVID-19 Patients: A Retrospective Analysis
by: João Oliveira, et al.
Published: (2021-07-01) -
Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)